Nexstim Has Received Three NBS System Orders in Europe

NEXT STORY
Global vaccine adjuvants market size to surpass USD 1,305 million mark by 2027
PREV STORY
Non-Oncology Precision Medicine Market, 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017

RANCHO CORDOVA, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a ...

author_avatar
NASDAQ Market News

XBiotech Publishes Results in PLOS ONE for its True Human Antibody 514G3 Targeting S. aureus

AUSTIN, Texas, Jan. 25, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today the ...

author_avatar
NASDAQ Market News

Vascular Biogenics Ltd. Closes $24 Million Registered Direct Offering

TEL AVIV, Israel, June 16, 2016 (GLOBE NEWSWIRE) -- Vascular Biogenics Ltd. (“VBL Therapeutics” ...

author_avatar
NASDAQ Market News